Outlook: British Biotech
Tuesday 16 February 1999
First there was the grand dream of creating a "New Glaxo", a whizzy pharmaceutical giant based on some unproven compounds. Then came the bitter tussle with Andrew Millar, its former chief scientist, who was sacked for examining clinical data on the company's leading products and blowing the whistle on overoptimistic statements. The corker of a row triggered two investigations by stock exchange authorities, a Parliamentary enquiry and a collapse in the share price. The faces around the boardroom table changed since then but the results have remained the same, witness yesterday's trial failure, which at least partially vindicates Dr Millar's actions.
The new men in charge claim that Marimastat can still work on other cancers and that there are nine other studies to prove it. Shareholders should be patient, they say, these are early days, give us another year. But this is asking a lot of investors who have seen the value of their shares plunge by almost 93 per cent over the past five years. After yesterday's events, there must be a serious question over the future of British Biotech.
The company has a strong balance sheet with cash of over pounds 100m. And it is only a couple of years since this company was the rising star in Britain's rapidly growing biotech sector. But given the dreadful track record and uncertain prospects perhaps the board should finally admit defeat.Would it not now be the honourable course to return the cash to the long-suffering investors and draw the curtains on this sorry tale?
- 1 The black and blue dress: Makers considering a white and gold version
- 2 Husband and wife die holding hands within hours of each other after 67 years of marriage
- 3 What color is The Dress, white and gold or blue and black? An eyewitness gives a definitive answer
- 4 The remarkable archaeological underwater discovery that could open up a new chapter in the study of European and British prehistory
- 5 Madonna claims jokes about her age tantamount to racism: 'No one would dare to say a degrading remark about being black'
Husband and wife die holding hands within hours of each other after 67 years of marriage
Mohammed Emwazi: Nine things we know about Isis militant 'Jihadi John'
What color is The Dress, white and gold or blue and black? An eyewitness gives a definitive answer
'Jihadi John': CAGE representative storms off Sky News accusing Kay Burley of Islamophobia
Madonna claims jokes about her age tantamount to racism: 'No one would dare to say a degrading remark about being black'
Oscars 2015: Birdman beats Boyhood as Eddie Redmayne and Patricia Arquette win big - as it happened
New theory could prove how life began and disprove God
Half of Ukip voters say they are prejudiced against people of other races
'Cash for access' scandal: Sir Malcolm Rifkind says 'unrealistic' for MPs to live on £67,000 salary
This is what it's like to be dead, according to a guy who died for a bit
Aqsa Mahmood branded a 'disgrace' by her parents after claims she recruited three UK girls flying to Middle East
iJobs Money & Business
£40000 - £50000 per annum + pro rata: SThree: SThree Group have been well esta...
£30000 - £37000 per annum: Recruitment Genius: Established in 1999, a highly r...
£250-£300 Day Rate: Jemma Gent: Are you a qualified accountant with strong exp...
£230 - £260 Day Rate: Jemma Gent: Do you want to stamp your footprint in histo...